Skip to content
PICO Portalanswers from OpenAlex

Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy

PaperCitations, authors & open-access status

Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy is a paper indexed in PICO Portal from OpenAlex.

How many citations does Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy have?

PICO Portalcitation count

Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy has 534 citations in the OpenAlex counts PICO Portal stores.

When was Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy published?

PICO Portalyear

Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy has 2003 year in the PICO Portal index.

What is the open-access status of Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy?

PICO Portaloa status

Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy has bronze oa status in the PICO Portal index.

What is the DOI of Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy?

PICO Portaldoi

The DOI for Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy is on the source record.

What is the PMID of Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy?

PICO Portalpmid

The PMID for Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy is on the source record.

What is the OpenAlex record for Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy?

PICO Portalopenalex

The OpenAlex for Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial